Hemoglobin subunit gamma 2 promoter CCAAT box (HBG2 CCAAT box)

The Hemoglobin subunit gamma 2 (HBG2) promoter CCAAT box is a critical cis-regulatory DNA element located within the promoter region of the G-gamma globin gene. It serves as a primary binding site for the Nuclear Factor Y (NF-Y) complex, which is essential for recruiting the transcription machinery required for fetal hemoglobin (HbF) production (Martyn et al., 2018, Nature Genetics). During normal human development, this region is subject to epigenetic silencing and the recruitment of repressor proteins, such as BCL11A and ZBTB7A (LRF), which facilitate the transition from fetal to adult hemoglobin (Wienert et al., 2018, Human Molecular Genetics). This DNA element has emerged as a major therapeutic target for genomic medicines aimed at treating sickle cell disease and beta-thalassemia. By utilizing gene-editing technologies like CRISPR/Cas9 or base editors to introduce specific mutations or deletions within or near the CCAAT box, researchers can disrupt repressor binding or mimic the phenotype of Hereditary Persistence of Fetal Hemoglobin (HPFH) (Traxler et al., 2016, Nature Medicine). These therapeutic interventions aim to restore high levels of HbF in adult red blood cells, thereby compensating for defective adult beta-globin and reducing the clinical severity of hemoglobinopathies (Editas Medicine, 2024; Beam Therapeutics, 2024).

Other names

G-gamma globin promoter CCAAT boxHBG2 distal CCAAT boxHBG2 proximal CCAAT boxHBG2 promoter elementGamma-globin promoter CCAAT motif

Reactivation of fetal hemoglobin (HbF) expression through genomic modification of the promoter to disrupt repressor binding sites (e.g., BCL11A or ZBTB7A) or to mimic naturally occurring HPFH mutations.